HIV/Aids

13 November 2006

Progress on HIV vaccine

A combination of two vaccines - one genetically-derived - has proved effective against HIV in human clinical trials.

0
A combination of two vaccines - one genetically-derived - has proved effective against HIV in human clinical trials.

While not claiming complete success, US National Institute of Health researchers says the vaccines, administered in combination, produced good results, especially the one that was DNA-based. It was found to be "safe and well-tolerated," according to a news release from the Infectious Disease Society of America.

Two problems still exist, the scientists say. The DNA-based vaccine is less potent than other anti-Aids immunisations, and the other vaccine may be subject to some outside influence.

The findings are published online in the December 15 issue of The Journal of Infectious Diseases. – (HealthDayNews)

Read more:
HIV/Aids Centre

November 2006

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria before working for an HIV/AIDS NPO in Soweto for many years. She was named one of the Mail & Guardian's Top 200 Young South Africans in 2012.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules